Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer

Dahele, Max; Brade, Anthony; Pearson, Shannon; Bezjak, Andrea
June 2009
CMAJ: Canadian Medical Association Journal;6/23/2009, Vol. 180 Issue 13, p1326
Academic Journal
The article offers information on stereotactic body radiation therapy (SBRT), its administration and effects in patients with peripheral tumours. It relates that is SBRT is the historical standard treatment for patients with early-stage, peripheral non-small-cell lung cancer who cannot undergo surgery. It pertains that this therapy has been proven to be effective and well tolerated, however, not all patients with the above-mentioned type of lung cancer are eligible for this kind treatment relative to the location of the tumour. Furthermore, it suggests that stereotactic radiotherapy has not caused any adverse effects on quality of life, however, its toxicity has late symptoms such as chest wall pain, low-grade fatigue, and erythema.


Related Articles

  • Stereotactic radiotherapy, wedge resection options for borderline operable NSCLC.  // Hem/Onc Today;2/25/2010, Vol. 11 Issue 4, p43 

    The article discusses the use of stereotactic radiotherapy and wedge resection as options for borderline operable non-small cell lung cancer (NSCLC).

  • New Lung Cancer Therapy Found Effective.  // AARC Times;Jun2010, Vol. 34 Issue 6, p74 

    The article presents a study which shows that a noninvasive procedure named stereotactic body radiation therapy (SBRT) was efficient in removing the recurrence of primary lung cancer in 98% of 5 patients determined with early-stage non-small-cell lung cancer.

  • STEREOTACTIC CONFORMAL RADIOTHERAPY IN PATIENTS WITH LUNG CANCER AND CARDIOVASCULAR PATHOLOGY. Anikeeva, O. Yu.; Polovnikov, E. S.; Bednyi, I. V.; Filatov, P. V. // Oncosurgery / Onkohirurgia;2012, Vol. 4 Issue 3, p23 

    The techniques of stereotactic radiotherapy in patients with non-small cell lung cancer with concurrent cardiovascular pathology with active breathing control system is represented in the article. Material and methods: stereotactic conformal radiotherapy was performed in 26 patients with...

  • Stereotactic body radiotherapy (SBRT) for non-pathologically diagnosed lung cancer patients. Harkenrider, Matthew M.; Bertke, Matthew H.; Dunlap, Neal E.; Dragun, Anthony E. // Journal of Solid Tumors;Jun2012, Vol. 2 Issue 3, p4 

    Objective: Medically inoperable patients with primary or recurrent lung cancer are increasingly being diagnosed clinically without pathologic confirmation especially for patients with comorbidities that preclude biopsy. The objective of this study is to report the outcomes of medically...

  • Developments in early-stage NSCLC: advances in radiotherapy. Verstegen, N. E.; Lagerwaard, F. J.; Senan, S. // Annals of Oncology;Sep2012 Supplement 10, Vol. 23 Issue suppl_10, px46 

    An increase in the number of predominantly elderly patients with early-stage non-small-cell lung cancer is anticipated in many Western populations. Patients often have major co-morbidities and are at increased risk for surgical morbidity and mortality. In the past decade, the use of stereotactic...

  • Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands. Haasbeek, C. J. A.; Palma, D.; Visser, O.; Lagerwaard, F. J.; Slotman, B.; Senan, S. // Annals of Oncology;Oct2012, Vol. 23 Issue 10, p2743 

    Background Elderly patients with stage I non-small-cell lung cancer are less likely to undergo curative treatment. However, the introduction of new treatment options such as stereotactic ablative radiotherapy (SABR) may improve treatment rates. We evaluated time trends in treatment patterns and...

  • Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer. Timmerman, Robert; Paulus, Rebecca; Galvin, James; Michalski, Jeffrey; Straube, William; Bradley, Jeffrey; Fakiris, Achilles; Bezjak, Andrea; Videtic, Gregory; Johnstone, David; Fowler, Jack; Gore, Elizabeth; Choy, Hak // JAMA: Journal of the American Medical Association;3/17/2010, Vol. 303 Issue 11, p1070 

    The article focuses on a study which evaluated the toxicity and efficacy of stereotactic body radiation therapy in a high-risk population of patients 18 years and older with early stage but medically inoperable lung cancer. The prescription dose of the radiation was 18 Gy per fraction x 3...

  • Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases. Xiang-Pan Li; Jian.Ping Xiao; Xiu-Jun Chen; Xue-Song Jiang; Ye Zhang; Ying-Jie Xu // Journal of Cancer Research & Therapeutics;Jul-Sep2014, Vol. 10 Issue 3, p597 

    Objective: Patients with small-cell lung cancer (SCLC) are at high risk of developing brain metastases (BM). Fractionated stereotactic radiotherapy (FSRT) alone or combined with whole brain radiation therapy can be used to treat intracranial metastases. This study was aimed to explore FSRT for...

  • REVIEW ON RAPID ARC BASED STEREOTACTIC BODY RADIOSURGERY FOR LUNG, HEAD AND NECK CANCER. Baskaran, R.; Antoinette, B. // Asian Journal of Pharmaceutical & Clinical Research;Jan-Mar2012 Supplement, p5 

    Steriotactic body radiation therapy is a newly emerging radiotherapy treatment method to deliver a high dose of radiation to the target in a single dose or number of fractions. The features of SBRT patients both normal and abnormal tissue are defined with CT, MRI, or angiography or any other...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics